Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-20-024667
Filing Date
2020-12-01
Accepted
2020-12-01 17:31:16
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A atos20201129_s1a.htm S-1/A 443191
2 FORM OF UNDERWRITING AGREEMENT ex_216053.htm EX-1.1 245348
3 EXHIBIT 3.8 ex_215977.htm EX-3.8 82440
4 EXHIBIT 4.9 FORM OF WARRANT ex_215978.htm EX-4.9 112622
5 EXHIBIT 4.10 WARRANT AGENCY AGREEMENT ex_215994.htm EX-4.10 119618
6 EXHIBIT 5.1 OPINION OF GIBSON, DUNN & CRUTCHER LLP ex_215979.htm EX-5.1 10620
7 EXHIBIT 23.1 AUDITORS' CONSENT ex_215980.htm EX-23.1 3870
8 atos20201129_s1aimg001.jpg GRAPHIC 6040
9 banner.jpg GRAPHIC 16823
10 gdlogo.jpg GRAPHIC 4855
  Complete submission text file 0001437749-20-024667.txt   1057291
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-250820 | Film No.: 201361778
SIC: 2834 Pharmaceutical Preparations